Segment disclosures

Company overview

셀트리온제약

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-03-3185551417692 KRW20210514Open filing evidence
2020-01-01 – 2020-12-31233568477708 KRW20210318Open filing evidence
2020-07-01 – 2020-09-3065491837462 KRW20201116Open filing evidence
2020-01-01 – 2020-09-30156274143846 KRW20201116Open filing evidence
2020-04-01 – 2020-06-3046393015625 KRW20200814Open filing evidence
2020-01-01 – 2020-06-3090782306384 KRW20200814Open filing evidence
2020-01-01 – 2020-03-3144389290759 KRW20210514Open filing evidence
2019-01-01 – 2019-12-31173512796760 KRW20210318Open filing evidence
2019-07-01 – 2019-09-3047435556126 KRW20201116Open filing evidence
2019-01-01 – 2019-09-30128646272489 KRW20201116Open filing evidence
2019-04-01 – 2019-06-3042621269467 KRW20200814Open filing evidence
2019-01-01 – 2019-06-3081210716363 KRW20200814Open filing evidence
2019-01-01 – 2019-03-3138589446896 KRW20200515Open filing evidence
2018-01-01 – 2018-12-31146880153915 KRW20210318Open filing evidence
2018-07-01 – 2018-09-3034737748317 KRW20191114Open filing evidence
2018-01-01 – 2018-09-3096356349700 KRW20191114Open filing evidence
2017-01-01 – 2017-12-31135860255627 KRW20200330Open filing evidence